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1. Introduction 
Steroids, drugs and certain chemicals stimulate the 
synthesis of porphyrins in avian liver cells by inducing 
the de novo formation of 6-aminolevulinate synthetase 
(ALAS), the rate-limiting enzyme in the porphyrin- 
heme biosynthetic pathway [l-3]. This chemically- 
induced hepatic porphyria has proved to be a useful 
experimental model for examining pathogenetic mech- 
anisms in the natural disorders of porphyrin metabol- 
ism in man. The excess porphyrins synthesized by 
avian liver cells treated with porphyrinogenic chemi- 
cals accumulate in these cells in very high concentra- 
tions [ 1,4] ; similarly high concentrations of porphyr- 
ins accumulate in the liver in certain of the human 
porphyrias. The pharmacological effects which these 
porphyrins may have on the various metabolic pro- 
cesses of hepatic cells are not known. In the course of 
other studies, we observed that in liver cells treated 
with the potent porphyrinogenic agent allylisopropyl- 
acetamide (AIA), the incorporation of “C-leucine 
into proteins in vitro was significantly less than in un- 
treated cultures. This effect was unexpected in light 
of the known increase in liver enzyme synthesis which 
takes place in experimental porphyria [5,6] ; more- 
over the inhibition of 14C-leucine incorporation into 
protein was observed only during the latter part of 
the induction period when porphyrins are present in 
great excess in the treated hepatic cells. Such inhibi- 
tion was also noted when exogenous b-aminolevulinic 
acid (ALA) was added to the cultures and transformed 
by the cell into porphyrins. 
These findings led us to examine the direct effects 
of porphyrins on amino acid incorporation into pro- 
tein by cultured liver cells. The results of these experi- 
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ments, which indicate that excessive concentrations 
of coproporphyrins in liver cells inhibit amino acid 
uptake into proteins by an as yet unknown mechan- 
ism, are reported here. 
2. Experimental 
Chick embryo liver cells were grown in primary 
cultures on 16 mm cover slips or in 100 mm diam. 
plastic petri dishes by the method of Granick [ 1 ] . 
The medium was replaced after 15-24 hr at which 
time various compounds were added to the cultures 
and incubation continued for an additional 18-24 
hr. The culture medium was removed immediately 
prior to labelling with 14C-leucine, frozen and saved 
for quantitative analysis of porphyrins utilizing our 
previously described procedure [7]. Warm (37”) 
leucine-free medium (Microbiological Associates) and 
14C-L-leucine (New England Nuclear, 260 mCi/mmole) 
were then immediately added to the cultures and the 
cells exposed to 14C-leucine (450,000 cpm/ml) for 
30 min. After this pulse-labelling, the cells were rinsed 
with appropriate buffer and processed as described 
under tables 1 and 2. Radioactivity was determined 
in a mixture of Omnifluor (New England Nuclear) 
and toluene with an efficiency of approx. 98% in a 
Packard scintillation spectrometer. The quantitative 
values reported are based on the means of 14C-leucine 
incorporation observed in 5 vials and are representative 
of replicate experiments. Protein was determined by 
the method of Lowry et al. [8] with bovine serum 
albumin as standard. 
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Table 1 
Effect of porphyrinogenic compounds and coproporphyrins on the in vitro incorporation 
of 14C-L-leucine into proteins of chick embryo liver cell cultures. 
Exp. Cells Incubation 
time 
Porphyrins 14C-L-leucine incorporation 
(hr) (pmoles/ml f S.D.) (cpm/vial * S.D.) Inhibition P 
(%) 
1 Control. 24 17.1 + 6.8 4987 * 684 0 
AIA 24 90.3 f 5.1 3217 f 508 -36 <0.005 
2 Control 22 12.9 + 7.1 6990 f 653 0 
AIA 22 46.9 * 7.9 3658 f 420 -48 <O.OOl 
ALA 22 97.3 * 16.8 2588 f 516 -63 <O.OOl 
3 Control 18 10.8 ? 2.2 5488 f 347 0 
Copro III 18 260. r 4.1 3614 t 400 -34 <o.oos 
4 Control 24 17.7 i: 1.2 6705 t 1187 0 
Copro I 24 152. + 1.2 3517 +_ 763 -48 <O.OOl 
Liver cells were grown on cover slips for 22 hr prior to addition of 30 c(g of AIA or 100 c(g of ALA in 5 A of HaO/ml of medium 
or 150-260 pmoles of co ro I and III, respectively, per ml medium with subsequent incubation for the times indicated. Cells were 
labelled for 30 min with tg C-leucine as described in the text, washed several times in cold phosphate-saline, fixed 10 min in acetic 
acid-alcohol at 4”, extracted 1 hr with 2% HClO and rinsed extensively with water according to the procedure of Franklin [lo]. 
Cells were solubilized in 0.5 ml of soluene (Packard) and radioactivity determined as described in the text. The porphyrin content 
of the medium is the mean of 5 individually assayed culture vials with copro III as standard [ 71 ; *4C-leucine incorporation by liver 
cells is the mean of 5 cover slips; S.D. is the standard deviation. P values of f-test are highly significant. 
3. Results and discussion 
The results in table 1 show that addition of the 
porphyrinogenic chemical AIA to avian embryo hepa- 
tocytes grown in primary cultures stimulated the syn- 
thesis of porphyrins, as expected, their concentration 
in the medium reaching 5 times the levels in control 
cultures after 24 hr of incubation. The concentration 
of porphyrins in the cells themselves exceeds that in 
the medium [ 1,4] . However r4C-leucine incorporation 
into protein by these AIA-induced liver cells was de- 
creased significantly as compared with controls (exp. 
1,2). The inhibition was observed consistently in simi- 
lar experiments, but occurred only towards the latter 
part of the incubation period when porphyrins are 
known to accumulate in the cells and medium of the 
cultures [ 1,4] . To ascertain that this inhibition was 
not due to some artifact specifically involving i4C-leu- 
tine incorporation in vitro, in other experiments cells 
induced with AIA were pulse-labelled with a i4C-amino 
acid mixture or with r4C-guanido-L-arginine, an amino 
acid which is not reutilized [9], and similar results 
were obtained. The results with the latter amino acid 
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exclude artifacts resulting from reutilization of the 
label and also suggest hat the inhibition effect relates 
to protein biosynthetic rather than catabolic or other 
processes in the cell. 
To examine further the relationship between the 
presence of excess porphyrins in the AIA-treated cul- 
tures and the incorporation of “C-leucine by the cell 
monolayer, synthesis of porphyrins was increased in 
control cultures by exogenous addition of ALA, the 
product of the enzymatic reaction catalyzed by ALAS. 
No inhibitory effect on r4C-leucine incorporation in 
vitro was observed when ALA was present in the cul- 
tures for 1 hr; however when the ALA was allowed to 
be transformed into porphyrins by the cells during a 
further 22 hr of incubation, a pronounced inhibition 
of 14C-leucine incorporation into protein was observed. 
This inhibition was of a greater degree than that ob- 
served in the AIA-treated cultures (table 1, exp. 2). If 
porphyrins in the liver cell cultures produced this in- 
hibition of protein synthesis, they would be expected 
to act directly in control cultures, as well as after 
having been formed by the cells from ALA or via in- 
duction of ALAS by AIA. The results shown in table 1 
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Table 2 
Inhibition of 14C-L-leucine incorporation into protein from homogenates 
of chick embryo liver cell cultures treated with AIA and coproporphyrin III. 
June 1972 
Cells Incubation 
time 
Porphyrins Protein 14C-L-leucine incorporation Inhibition 
(hr) (pmole/ml f S.D.) @g/ml f S.D.) (cpm/ml f SD.) (cpm//.rg f S.D.) (%) P 
Control 24 4.03 + 0.3 528 f 1.8 19708 + 780 37.3 f 1.5 0 
AIA 24 59.5 f 0.9 480 f 1.8 12769 + 280 25.6 f 0.6 -29 <D.ilOl 
Copro III 24 94.1 f 1.2 484 f 3.5 14215 f 93 29.4 f 0.2 -21 <o.oos 
Liver cells were grown in petri dishes (100 mm in diam.) for 15 hr prior to addition of AIA and copro III (50 fig and 177 pmole/ 
ml of medium, respectively) with subsequent incubation for 24 hr. Medium was removed at the end of the incubation and its 
coproporphyrin content determined [ 71. The cell monolayer was then labelled with 14C-leucine for 30 min aa described in the 
text. Cells were rinsed twice with 0.05 M Tris, pH 7.4, scraped from the bottom of plates and homogenized in this buffer. Tripli- 
cate aliquots of each homogenate fraction were precipitated with 10% TCA, washed 3 times with 5% TCA by centrifugation and 
solubilized in 0.5 ml of soluene. Radioactivity was determined as described in the text. S.D. is the standard deviation; P values of 
the t test are highly significant. 
(exp. 3,4) show this to be the case. In these experi- 
ments, and similar ones not reported, coproporphyrins 
I and III (copro I and III) consistently and significantly 
inhibited 14C-leucine incoporation into protein; hemin, 
at comparable concentration did not have this effect. 
Inhibition with copro I and III was apparent as 
early as 1 hr after they were added to the cultures, 
and the effect persisted as long as the liver cells were 
exposed to the compounds. Since determination of 
the protein content of the 14C-labelled liver cells 
grown on coverslips was not feasible because of the 
need for fixation and isotope counting of the mono- 
layer the effect of AIA and copro III on “C-leucine 
incorporation was also determined in homogenates of 
cells grown in 100 mm diameter plastic petri dishes. 
The results expressed as “specific activity” (with res- 
pect to the protein content of the labelled aliquots of 
homogenized cells) are shown in table 2; inhibition of 
14C-leucine uptake is again apparent in the porphyrin 
treated cell cultures verifying the observations made in 
the experiments shown in table 1. 
The mechanism for the coproporphyrin effect on 
the uptake of amino acids into proteins by liver cells 
is not yet established. Although porphyrins have been 
reported to have an affinity for plasma proteins and 
lipoproteins [ 11, 121 they are also chelating agents 
for various divalent ions [ 131. The culture medium 
used in these experiments however contains a large 
excess of Mg2+, a cation essential for activation of 
various enzymes and for protein biosynthesis. A por- 
phyrin interaction with plasma membranes to prevent 
entry of labelled amino acids into the liver cell seems 
l4 unlikely since C- leucine incorporation by cytosol 
fractions of embryonic avian hepatocytes was also in- 
hibited by these compounds. 
Whatever their proximate mode of action, the abil- 
ity of coproporphyrins to inhibit the rate of amino 
acid incorporation into liver cell proteins is significant 
and needs to be taken into account when evaluating 
kinetic parameters of specific proteins, i.e. enzymes, 
in porphyric avian hepatocytes. 
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